Zoetis, the world’s leading animal health company, is participating in the International Animal Protein Show (SIAVS), the main industry event in Brazil. Held in São Paulo, SIAVS brings together the key players in the animal protein production chain, including poultry, swine and cattle.
With a comprehensive portfolio of medicines and solutions for food producing and companion animals that support veterinarians and industry professionals with more than 300 product lines, Zoetis brings to SIAVS some of its main solutions for poultry, cattle, swine and fish.
“For us, it is very important to support an event like this, which brings together the entire animal protein production chain. The role of animal health companies in the protein production process is essential so that members of the production chain can meet sustainability goals through healthier and more productive animals. In this context, Zoetis operates in line with the continuous animal health care cycle, which includes predicting through genetics, preventing through vaccines, diagnosing through detection and treating diseases,” says Luis Xavier Rojas, President of the company, who will also be present on the first day of the event.
This year, the company will showcase the innovative tilapia vaccination machine Fishteq NFT20 at its booth. In addition to vaccinating, the machine counts, measures and grades fish. “Brazil is the first country to vaccinate tilapia using this equipment, which is already successfully used in other countries for the automatic vaccination of species such as salmon and trout. Since its launch, this new technology has contributed to increasing the efficiency of tilapia farming in the country,” says Renato Verdi, Director of the Poultry, Swine and Aquaculture Business Unit at Zoetis.
In poultry production, the company has focused on developing hatchery solutions. For this reason, Eduardo Muniz, Technical Services and Applied Research Manager at Zoetis and PhD in Avian Pathology, will present the lecture “In ovo vaccination: from A to Z”.
Still regarding hatchery solutions, the company recently launched Poulvac Procerta HVT IBD to expand its portfolio of vectored vaccines. “This vaccine is a powerful and updated tool to protect flocks against Gumboro and Marek viruses circulating among broiler operations in Brazil, including variant strains of Gumboro,” says veterinarian Gleidson Salles, Marketing Manager for the Poultry Unit at Zoetis. Recombinant vaccines with an HVT vector offer flexibility, as they can be administered both in ovo and via the subcutaneous route. They also provide long lasting immunity.
Featured products
Dectomax - A broad spectrum injectable parasiticide for cattle, swine and sheep. It has a wide safety margin, is exceptionally well tolerated and easy to apply. It is particularly suitable for controlling parasites in cattle, swine and sheep.
Fostera Gold PCV MH - The first combined vaccine against PCV and M hyo, with a flexible one or two dose protocol. It combats the respiratory diseases that cause the greatest losses in swine herds.
Inovoject NXT in ovo vaccination machine - This technology provides efficient vaccination with no product waste, agility and biosecurity, ensuring process productivity combined with animal welfare. Chicks are already vaccinated at hatch against diseases such as Marek and Gumboro and do not need to undergo the stress of vaccination immediately after hatching.
Poulvac Maternavac Ultra 5. A alta demanda por proteína animal e a necessidade de uma produção mais eficiente e de melhor qualidade estimulam o setor de proteína animal a seguir a agenda de Governança Ambiental, Social e Corporativa (ESG, na sigla em inglês). Nesse contexto, a sustentabilidade está na base das operações e do desenvolvimento dos produtos da companhia, o que fica evidente com a Poulvac Maternavac Ultra 5, uma vacina inovadora que permite compilar a proteção contra 5 enfermidades em aves como medida auxiliar na prevenção da Doença de Gumboro (IBD), Reovirose (REO), Doença de Newcastle (NDV), Bronquite Infecciosa (IBV) e Metapneumovirose aviária (aMPV). Ela promove proteção completa em apenas uma única aplicação, com menos descartes após o uso e redução do impacto para o planeta.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture the world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect and treat animal diseases for more than 70 years, Zoetis continues to support those who raise and care for animals around the world, from veterinarians and pet owners to livestock producers and farmers. The company’s leading portfolio of medicines, vaccines, diagnostics and technologies makes a difference in more than 100 countries. A Fortune 500 company, Zoetis generated revenue of US$ 8.54 billion in 2023 and employs approximately 13,800 people. For more information, click here.
Press information | Little George
Jaqueline Frederes – jaqueline.frederes@littlegeorge.com.br
Adriana Ferreira – adriana.ferreira@littlegeorge.com.br
